You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

oBINutuzumab

( oh-bi-nue-tooz-ue-mab )
Funding:
New Drug Funding Program
  • Obinutuzumab - Previously Untreated Chronic Lymphocytic Leukemia
  • Obinutuzumab - In Combination with Chemotherapy for Refractory Follicular Lymphoma
  • Obinutuzumab - Maintenance Treatment for Refractory Follicular Lymphoma
Other Name(s): Gazyva®
Appearance: solution mixed into larger bags of fluids

You might also be interested in